Iqbal Muhammad, Fan Tai-Ping, Watson David, Alenezi Samya, Saleh Khaled, Sahlan Muhamad
Department of Pharmacology, University of Cambridge, Cambridge, United Kingdom.
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.
Heliyon. 2019 Jul 19;5(7):e01978. doi: 10.1016/j.heliyon.2019.e01978. eCollection 2019 Jul.
Several studies have previously reported propolis, or its constituents, to inhibit tumour angiogenesis. The anti-angiogenic activity of two Indonesian stingless bee propolis extracts from Sulawesi Island on vascular cells were assessed. Sample D01 was obtained from the outer side of bee hives, while D02 was from the inner side of the same hives. The extracts were profiled by using liquid chromatography coupled to high resolution mass spectrometry. The anti-angiogenic capacity was assessed on HUVECs and placenta-derived pericytes by cell viability, multi-channel wound healing, and CoCl based-hypoxia assays. The exact chemical composition has not been confirmed. The most abundant compounds in Indonesian sample D01 seem to be unusual since they do not immediately fall into a clear class. Two of the most abundant compounds have elemental compositions matching actinopyrones. Identification on the basis of elemental composition is not definitive but compounds in D01 are possibly due to unusually modified terpenoids. Sample D02 has abundant compounds which include four related diterpenes with differing degrees of oxygenation and some sesquiterpenes. However, again the profile is unusual. The anti-angiogenic assays demonstrated that D01 elicited a strong cytotoxic effect and a considerable anti-migratory activity on the vascular cells. Although D02 demonstrated a much weaker cytotoxic effect on the cell lines compared to D01, it elicited a substantial protective effect on the pericytes against CoCl-induced dropout in an experiment to mimic a micro-environment commonly associated with angiogenesis and tumour growth. These results demonstrate modulatory effects of these propolis samples in vascular cells, which requires further investigation.
此前已有多项研究报道蜂胶或其成分可抑制肿瘤血管生成。评估了两种来自苏拉威西岛的印尼无刺蜂蜂胶提取物对血管细胞的抗血管生成活性。样品D01取自蜂巢外侧,而D02取自同一蜂巢内侧。提取物通过液相色谱与高分辨率质谱联用进行分析。通过细胞活力、多通道伤口愈合和基于CoCl的缺氧试验评估了对人脐静脉内皮细胞(HUVECs)和胎盘来源周细胞的抗血管生成能力。确切的化学成分尚未得到证实。印尼样品D01中最丰富的化合物似乎不同寻常,因为它们不能立即归入明确的类别。其中两种最丰富的化合物的元素组成与放线菌酮匹配。基于元素组成的鉴定并不确定,但D01中的化合物可能是异常修饰的萜类化合物。样品D02含有丰富的化合物,包括四种氧化程度不同的相关二萜和一些倍半萜。然而,其图谱同样不同寻常。抗血管生成试验表明,D01对血管细胞具有强烈的细胞毒性作用和显著的抗迁移活性。尽管与D01相比,D02对细胞系的细胞毒性作用要弱得多,但在模拟通常与血管生成和肿瘤生长相关的微环境的实验中,它对周细胞具有显著的保护作用,可防止CoCl诱导的细胞脱落。这些结果表明这些蜂胶样品对血管细胞具有调节作用,这需要进一步研究。